Volume 23, Issue 6, Pages (June 2015)

Slides:



Advertisements
Similar presentations
Conformational Heterogeneity in the Activation Mechanism of Bax
Advertisements

Volume 20, Issue 8, Pages (August 2012)
Volume 14, Issue 3, Pages (March 2006)
Volume 24, Issue 7, Pages (July 2016)
Volume 19, Issue 8, Pages (August 2011)
Volume 13, Issue 7, Pages (July 2005)
RecA-Binding pilE G4 Sequence Essential for Pilin Antigenic Variation Forms Monomeric and 5′ End-Stacked Dimeric Parallel G-Quadruplexes  Vitaly Kuryavyi,
Volume 18, Issue 6, Pages (June 2005)
Volume 22, Issue 11, Pages (November 2014)
Volume 24, Issue 12, Pages (December 2016)
Volume 9, Issue 11, Pages (November 2001)
Volume 23, Issue 7, Pages (July 2015)
Solution Structure of a Unique G-Quadruplex Scaffold Adopted by a Guanosine-Rich Human Intronic Sequence  Vitaly Kuryavyi, Dinshaw J. Patel  Structure 
Volume 108, Issue 6, Pages (March 2015)
Volume 19, Issue 7, Pages (July 2011)
Structure and RNA Interactions of the N-Terminal RRM Domains of PTB
Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity
Volume 12, Issue 9, Pages (September 2005)
Volume 13, Issue 9, Pages (December 2015)
Nadine Keller, Jiří Mareš, Oliver Zerbe, Markus G. Grütter  Structure 
Volume 25, Issue 12, Pages e3 (December 2017)
Volume 25, Issue 5, Pages e3 (May 2017)
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
Yizhou Liu, Richard A. Kahn, James H. Prestegard  Structure 
Leonardus M.I. Koharudin, Angela M. Gronenborn  Structure 
Volume 21, Issue 10, Pages (October 2013)
Volume 24, Issue 7, Pages (July 2016)
Nicholas J Skelton, Cliff Quan, Dorothea Reilly, Henry Lowman 
Volume 113, Issue 12, Pages (December 2017)
A Conformational Switch in the CRIB-PDZ Module of Par-6
Volume 20, Issue 12, Pages (December 2012)
Volume 23, Issue 5, Pages (May 2015)
Structural Analysis of Ligand Stimulation of the Histidine Kinase NarX
Volume 18, Issue 6, Pages (June 2010)
Structural Basis of Prion Inhibition by Phenothiazine Compounds
André Schiefner, Michaela Gebauer, Antonia Richter, Arne Skerra 
Volume 21, Issue 6, Pages (June 2013)
The Structure of the Tiam1 PDZ Domain/ Phospho-Syndecan1 Complex Reveals a Ligand Conformation that Modulates Protein Dynamics  Xu Liu, Tyson R. Shepherd,
Volume 17, Issue 10, Pages (October 2009)
A Functional Proline Switch in Cytochrome P450cam
Volume 13, Issue 2, Pages (February 2005)
Volume 19, Issue 9, Pages (September 2011)
Structural Basis for the Recognition of Methylated Histone H3K36 by the Eaf3 Subunit of Histone Deacetylase Complex Rpd3S  Chao Xu, Gaofeng Cui, Maria.
Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self- Assembled Tetramer  Yongheng Chen, Raja Dey, Lin Chen  Structure  Volume.
Volume 17, Issue 7, Pages (July 2009)
Volume 19, Issue 1, Pages (January 2011)
Autoinhibitory Structure of the WW Domain of HYPB/SETD2 Regulates Its Interaction with the Proline-Rich Region of Huntingtin  Yong-Guang Gao, Hui Yang,
Volume 16, Issue 6, Pages (June 2008)
Volume 13, Issue 7, Pages (July 2005)
Conformational Heterogeneity in the Activation Mechanism of Bax
Paolo A. Lobo, Lynn Kimlicka, Ching-Chieh Tung, Filip Van Petegem 
A Self-Sequestered Calmodulin-like Ca2+ Sensor of Mitochondrial SCaMC Carrier and Its Implication to Ca2+-Dependent ATP-Mg/Pi Transport  Qin Yang, Sven.
Volume 16, Issue 6, Pages (June 2008)
Volume 24, Issue 8, Pages (August 2016)
Volume 35, Issue 3, Pages (August 2009)
Volume 24, Issue 9, Pages (September 2016)
Unmasking the Annexin I Interaction from the Structure of Apo-S100A11
Volume 16, Issue 6, Pages (June 2008)
Volume 18, Issue 9, Pages (September 2010)
Volume 27, Issue 7, Pages e5 (July 2019)
Volume 20, Issue 4, Pages (April 2012)
Volume 25, Issue 9, Pages e3 (September 2017)
Volume 44, Issue 6, Pages (December 2011)
Volume 20, Issue 7, Pages (July 2012)
A Plug Release Mechanism for Membrane Permeation by MLKL
Volume 14, Issue 12, Pages (December 2006)
Volume 20, Issue 3, Pages (March 2012)
Autoinhibitory Structure of the WW Domain of HYPB/SETD2 Regulates Its Interaction with the Proline-Rich Region of Huntingtin  Yong-Guang Gao, Hui Yang,
Matthew T. Eddy, Tatiana Didenko, Raymond C. Stevens, Kurt Wüthrich 
RecA-Binding pilE G4 Sequence Essential for Pilin Antigenic Variation Forms Monomeric and 5′ End-Stacked Dimeric Parallel G-Quadruplexes  Vitaly Kuryavyi,
Presentation transcript:

Volume 23, Issue 6, Pages 1066-1077 (June 2015) Interactions of the Chemokine CCL5/RANTES with Medium-Sized Chondroitin Sulfate Ligands  Courtney Deshauer, Ashli M. Morgan, Eathen O. Ryan, Tracy M. Handel, James H. Prestegard, Xu Wang  Structure  Volume 23, Issue 6, Pages 1066-1077 (June 2015) DOI: 10.1016/j.str.2015.03.024 Copyright © 2015 Elsevier Ltd Terms and Conditions

Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Structure of CS444 and CS644 The difference in sulfation position at the non-reducing end GalNAc is highlighted in bold. Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 CS444-Induced Chemical Shift Changes in E66S CCL5 (A) 15N-HSQCs of E66S-CCL5 in the presence of different concentrations of CS444. The concentration of protein is 40 μM and the concentrations of CS444 are 0 (dark green), 20 (brown), 40 (yellow), 80 (pink), 120 (light green), and 160 (light blue) μM. Detailed sections showing movements of representative residues from the N loop and the 40s loop are shown on the right. (B) Scaled and combined chemical shift changes of each residue. The combined chemical shift changes were calculated using the formula ΔδS=ΔδH,Hz2+(1.7ΔδN,Hz)2. Positions of S5 and R45, which broadened beyond detection during the titration, are indicated by asterisks. Other residues missing from the graph are prolines. Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Sections of 15N-HSQCs of 30 μM E66S-CCL5 at 40°C (Black) E66S-CCL5 without CS444, both monomer and dimer species are visible. (Red) E66S-CCL5 with two molar equivalents of CS444. The assignments of signals representing monomeric and dimeric species are made based on (Schnur et al., 2013) and (Duma et al., 2007). Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 4 Quantitative Measurement of Paramagnetic TEMPO-Induced Transverse Relaxation (R2,PRE) (A) Graph and surface plot of amide proton R2,PRE produced by TEMPO-labeled CS444. (B) Graph and surface plot of amide proton R2,PRE produced by TEMPO-labeled CS644. Residues Y14, A16, and R21 disappeared upon addition of CS644-TEMPO but reappeared upon its reduction. They are given the same magnitude of R2,PRE as residue Y3, which showed the biggest change. Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 5 Intermolecular NOEs Detected between E66S CCL5 and CS444 (A) 13C-filtered/edited NOESY of 200 μM 13C-labeled E66S-CCL5 in the presence of one molar equivalent of CS444. CCL5 proton chemical shifts correspond to the X coordinates of the cross peaks while ligand proton chemical shifts correspond to the Y coordinates of the cross peaks. (B) HSQC-NOESYs of 200 μM deuterated E66S CCL5 with ILV methyl protonation in the presence (black) and absence (red) of one molar equivalent of CS444. Two new cross peaks can be seen in the spectrum collected in the presence of the ligand. They correspond to contacts between methyl groups on I15 and L19. Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 6 Cross Saturation Spectra of Deuterated E66S CCL5 Complexed to CS444 Reference 15N-HSQC (left) and STD 15N-HSQC (right) spectra of perdeuterated E66S-CCL5. Three residues showed the most prominent difference. Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 7 Saturation Difference Spectra of CS444 in the Presence of E66S CCL5 (A) STD 1D of 1 mM CS444 with 50 μM 13C-labeled E66S-CCL5. Possible assignments of the peaks are indicated. (B) Sections of F3-coupled HSQC-NOESY collected on the same sample. Cross peaks between ligand protons and protein protons can be seen. Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 8 Model of the CCL5 Dimer Complexed to CS444 (A) A representative frame from the most energetically favored models of the CCL5-CS444 complex. The ribbon representation of the complex with side chains of selective amino acids is shown in gray. The CS444 ligand is shown in the stick representation with the non-reducing end and the reducing end sugar labeled GlcA1 and GalNAc3, respectively. (B) Surface representation of the same structure with residues known to contact CS444 colored in blue. The protein is in the same orientation as (A). (C) Schematic illustration of the intermolecular hydrogen-bond contacts observed between E66S CCL5 and CS444. Curved arrows indicate contacts observed between CCL5 residues and functional groups on CS444 in the simulation. The percentages indicate the fraction of 50 most energetically favored frames containing the contact. Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 9 Comparisons of Chemokines’ Interactions with the Receptor N Terminus and E66S CCL5’s Interaction with GAGs (A) Structure of vMIP-II (surface) bound to N terminus of CXCR4 (ball-and-stick). (B) Model of vMIP-II bound to the CCR5 N terminus constructed using the crystal structure of the CXCR4-vMIP-II. Basic residues involved in contacting the CCR5 N terminus are colored in blue and labeled. (C) Model of CS444-bound CCL5 determined in this study. Basic residues involved in binding GAGs are colored in blue. (A) and (B) are adapted from Qin et al. (2015). Structure 2015 23, 1066-1077DOI: (10.1016/j.str.2015.03.024) Copyright © 2015 Elsevier Ltd Terms and Conditions